Merck Serono

Royalty Monetization$55 Million

Nov 2008

MarketerMerck Serono

Cetrotide® is a fertility drug commonly used in in-vitro fertilization procedures. The gonadotropin releasing hormone (GnRH) antagonist is used to prevent premature ovulation in controlled ovarian stimulation prior to assisted reproductive technologies (ART).

News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.